| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/AJPGI.00295.2004 |
| P698 | PubMed publication ID | 15528257 |
| P2093 | author name string | Rick Havinga | |
| Hugo R de Jonge | |||
| Henkjan J Verkade | |||
| Inez Bronsveld | |||
| Maarten Sinaasappel | |||
| Marcel J C Bijvelds | |||
| P2860 | cites work | cAMP-mediated inhibition of the epithelial brush border Na+/H+ exchanger, NHE3, requires an associated regulatory protein | Q24569613 |
| A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION | Q25939000 | ||
| Pancreatic triglyceride lipase deficiency minimally affects dietary fat absorption but dramatically decreases dietary cholesterol absorption in mice | Q28504948 | ||
| A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice | Q28505262 | ||
| Down-regulated in adenoma mediates apical Cl-/HCO3- exchange in rabbit, rat, and human duodenum | Q28566267 | ||
| Small-intestinal abnormalities in cystic fibrosis patients | Q34003555 | ||
| A molecular mechanism for aberrant CFTR-dependent HCO(3)(-) transport in cystic fibrosis | Q34206913 | ||
| Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilisation in pancreatic steatorrhoea due to cystic fibrosis | Q34527348 | ||
| Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model | Q35097413 | ||
| A fluorimetric and enzymatic method for the estimation of serum total bile acids | Q36622206 | ||
| Aberrant CFTR-dependent HCO3- transport in mutations associated with cystic fibrosis | Q40821697 | ||
| Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor | Q41226239 | ||
| Metabolism of the apolipoprotein B-containing lipoproteins | Q41364938 | ||
| Identification of transport abnormalities in duodenal mucosa and duodenal enterocytes from patients with cystic fibrosis | Q41738688 | ||
| A functional CFTR protein is required for mouse intestinal cAMP-, cGMP- and Ca(2+)-dependent HCO3- secretion. | Q42449164 | ||
| Fat absorption in germ-free and conventional rats artificially deprived of bile secretion | Q43255665 | ||
| Effects of omeprazole and pirenzepine on enterochromaffin-like cells and parietal cells in rat stomach | Q43655000 | ||
| Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis | Q43742899 | ||
| Pancreatic acinar cell dysfunction in CFTR(-/-) mice is associated with impairments in luminal pH and endocytosis | Q43770471 | ||
| cAMP inhibition of murine intestinal Na/H exchange requires CFTR-mediated cell shrinkage of villus epithelium | Q44601450 | ||
| The DeltaF508 mutation results in loss of CFTR function and mature protein in native human colon | Q44709432 | ||
| Additional disruption of the ClC-2 Cl(-) channel does not exacerbate the cystic fibrosis phenotype of cystic fibrosis transmembrane conductance regulator mouse models | Q44790624 | ||
| Acidic duodenal pH alters gene expression in the cystic fibrosis mouse pancreas | Q44830083 | ||
| No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis | Q45091549 | ||
| Production of a severe cystic fibrosis mutation in mice by gene targeting | Q45868497 | ||
| Bile acid kinetics and biliary lipid composition in cystic fibrosis. | Q51580700 | ||
| Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-Mediated Residual Chloride Secretion Does Not Protect against Early Chronic Pseudomonas aeruginosa Infection in F508del Homozygous Cystic Fibrosis Patients | Q51644964 | ||
| Postprandial chylomicron formation and fat absorption in multidrug resistance gene 2 P-glycoprotein-deficient mice. | Q52537428 | ||
| P433 | issue | 4 | |
| P921 | main subject | cystic fibrosis | Q178194 |
| P304 | page(s) | G646-53 | |
| P577 | publication date | 2004-11-04 | |
| P1433 | published in | American Journal of Physiology - Gastrointestinal and Liver Physiology | Q15765756 |
| P1476 | title | Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events | |
| P478 | volume | 288 |
| Q46613366 | Activation of CFTR by ASBT-mediated bile salt absorption |
| Q37175561 | Altered de novo lipogenesis contributes to low adipose stores in cystic fibrosis mice |
| Q37596433 | Bioelectric characterization of epithelia from neonatal CFTR knockout ferrets |
| Q33576842 | CFTR depletion results in changes in fatty acid composition and promotes lipogenesis in intestinal Caco 2/15 cells |
| Q35561131 | Cholic acid induces a Cftr dependent biliary secretion and liver growth response in mice |
| Q35216745 | Cystic fibrosis growth retardation is not correlated with loss of Cftr in the intestinal epithelium |
| Q43008641 | Defects in gallbladder emptying and bile Acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies. |
| Q34090196 | Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. |
| Q37206368 | Effect of antibiotic treatment on fat absorption in mice with cystic fibrosis. |
| Q37130749 | Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine |
| Q30502773 | Ezrin-mediated apical integrity is required for intestinal homeostasis |
| Q35693982 | Genetic Inhibition Of The Ubiquitin Ligase Rnf5 Attenuates Phenotypes Associated To F508del Cystic Fibrosis Mutation. |
| Q47406142 | IGF Binding Protein-3 Treatment Alters Intestinal Cell Proliferation But Not Body Weight of Adult Cystic Fibrosis Transmembrane Conductance Regulator Deficient Mice |
| Q93013565 | Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice |
| Q35281958 | Impaired mucosal barrier function in the small intestine of the cystic fibrosis mouse |
| Q94563709 | Improved residual fat malabsorption and growth in children with cystic fibrosis treated with a novel oral structured lipid supplement: A randomized controlled trial |
| Q47280680 | Intestinal phenotype of variable-weight cystic fibrosis knockout mice |
| Q37302555 | Knockout mouse models for intestinal electrolyte transporters and regulatory PDZ adaptors: new insights into cystic fibrosis, secretory diarrhoea and fructose-induced hypertension. |
| Q35185218 | Loss of intestinal GATA4 prevents diet-induced obesity and promotes insulin sensitivity in mice. |
| Q37887172 | Mouse models of cystic fibrosis: phenotypic analysis and research applications |
| Q33994808 | Pathophysiological preconditions promoting mixed "black" pigment plus cholesterol gallstones in a DeltaF508 mouse model of cystic fibrosis |
| Q34335468 | Purinergic regulation of duodenal surface pH and ATP concentration: implications for mucosal defence, lipid uptake and cystic fibrosis |
| Q92378159 | Slc26 Family of Anion Transporters in the Gastrointestinal Tract: Expression, Function, Regulation, and Role in Disease |
| Q83225906 | Systematic genetic analysis of the MHC region reveals mechanistic underpinnings of HLA type associations with disease |
| Q37122355 | The cystic fibrosis intestine |
| Q43169002 | The cystic fibrosis transmembrane conductance regulator (Cftr) modulates the timing of puberty in mice |
| Q36926385 | The ΔF508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Is Associated With Progressive Insulin Resistance and Decreased Functional β-Cell Mass in Mice. |
| Q48190174 | Ursodeoxycholate modulates bile flow and bile salt pool independently from the cystic fibrosis transmembrane regulator (Cftr) in mice |
Search more.